[1]
2025. Simultaneous method development and validation for Tenofovir AF, Emtricitabine, and Bictegravir by RP-UPLC. International Journal of Environmental Sciences. 11, 2s (Apr. 2025), 1202–1211. DOI:https://doi.org/10.64252/0my10m69.